Showing results (171-180 of 185) with videos related to
Sort By:
Pageof 19
Gastro Hep Advances|May 25, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Impaired Health-Related Quality of Life in People With HIVFelice Cinque, Michael Nudo, Sahar Saeed, et al.BMJ Open|May 26, 2026
Incidence and risk factors of C. trachomatis, N. gonorrhoeae and syphilis among a cohort of urban Canadian gay, bisexual and other men who have sex with men, 2017-2023: informing the potential impact of doxycycline prophylaxisGilles Lambert, Alain Fourmigue, Milada Dvorakova, et al.Science (New York, N.Y.)|March 9, 1990
Ribozymes as potential anti-HIV-1 therapeutic agentsN Sarver, E M Cantin, P S Chang, et al.CMAJ Open|May 22, 2021
Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort studyJoseph Cox, Herak Apelian, Erica E M Moodie, et al.BMJ Open|August 22, 2023
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohortFelice Cinque, Sahar Saeed, Dana Kablawi, et al.Neurogastroenterology and Motility|September 12, 2006
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal womenJ Gonenne, T Esfandyari, M Camilleri, et al.DNA (Mary Ann Liebert, Inc.)|May 1, 1988
Direct detection of HIV-1 RNA from AIDS and ARC patient samplesG J Murakawa, J A Zaia, P A Spallone, et al.Journal of Pharmaceutical Sciences|May 29, 2000
Identification of a yellow impurity in aged samples of aqueous butamben suspension: evidence for the oxidative degradation of poly(ethylene glycol)E J Ginsburg, D A Stephens, P R West, et al.Journal of Virology|October 1, 1988
Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 geneJ A Zaia, J J Rossi, G J Murakawa, et al.Prostate Cancer and Prostatic Diseases|August 22, 2012
Long-term effects of intermittent androgen suppression therapy on lean and fat mass: a 33-month prospective studyN A Spry, D R Taaffe, P J England, et al.Pageof 19